what kind of antibiotics are used for neisseria meningitidis
Neisseria meningitidis Persons with confirmed N. meningitidis infection should be hospitalized immediately for treatment with antibiotics. Because meningococcal disease can disseminate very rapidly, a single dose of intramuscular antibiotic is often given at the earliest possible opportunity, even before hospitalization, if disease symptoms look suspicious enough.[5] Third-generation cephalosporin antibiotics (i.e. cefotaxime, ceftriaxone) should be used to treat a suspected or culture-proven meningococcal infection before antibiotic susceptibility results are available.[32] Empirical treatment should also be considered if a lumbar puncture, to collect CSF for laboratory testing, cannot be done within 30 minutes of admission to hospital.[33][34] Antibiotic treatment may affect the results of microbiology tests, but a diagnosis may be made on the basis of blood-cultures and clinical examination.[35]
Rifampicin Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, leprosy, and Legionnaire's disease.[2] It is almost always used along with other antibiotics, except when given to prevent Haemophilus influenzae type b and meningococcal disease in people who have been exposed to those bacteria.[2] Before treating a person for a long period of time, measurements of liver enzymes and blood counts are recommended.[2] Rifampicin may be given either by mouth or intravenously.[2]
Bubonic plague Prevention is through public health measures such as not handling dead animals in areas where plague is common.[1] Vaccines have not been found to be very useful for plague prevention.[1] Several antibiotics are effective for treatment including streptomycin, gentamicin, and doxycycline.[3][4] Without treatment it results in the death of 30% to 90% of those infected.[1][3] Death, if it occurs, is typically within ten days.[6] With treatment the risk of death is around 10%.[3] Globally there are about 650 documented cases a year which result in ~120 deaths.[1] The disease is most common in Africa.[1]
Bubonic plague Prevention is through public health measures such as not handling dead animals in areas where plague is common.[1] Vaccines have not been found to be very useful for plague prevention.[1] Several antibiotics are effective for treatment, including streptomycin, gentamicin, and doxycycline.[3][4] Without treatment, plague results in the death of 30% to 90% of those infected.[1][3] Death, if it occurs, is typically within ten days.[6] With treatment the risk of death is around 10%.[3] Globally there are about 650 documented cases a year, which result in ~120 deaths.[1] In the 21st century, the disease is most common in Africa.[1]